Endocr Pract. 2016 Oct;22(10):1216-1223. doi: 10.4158/EP161380.OR. Epub 2016 Jul 13.
To assess the performance of biochemical markers in the detection of recurrent Cushing disease (CD), as well as the potential benefit of early intervention in recurrent CD patients with elevated late-night salivary cortisol (LNSC) and normal urinary free cortisol (UFC).
The design was a single-center, retrospective chart review. Patients treated by the authors from 2008-2013 were included. Recurrence was defined by postsurgical remission of CD with subsequent abnormal LNSC, UFC, or dexamethasone suppression test (DST).
We identified 15 patients with postsurgical recurrent CD after initial remission; all but one underwent testing with LNSC, DST, and UFC. Although 12 of 15 patients had normal UFC at time of recurrence, DST was abnormal in 11 of 15, and all 14 patients with LNSC results had ≥1 elevated measurement. Nine patients (7 with normal UFC) showed radiologic evidence of a pituitary tumor at time of recurrence. Among the 14 patients with available follow-up data, 12 have demonstrated significant improvement since receiving treatment. Five patients underwent repeat pituitary surgery and 4 achieved clinical and biochemical remission. Eight patients received mifepristone or cabergoline, and 6 showed clinical and/or biochemical improvement. Three patients (2 with prior mifepristone) underwent bilateral adrenalectomy and 2 demonstrated significant clinical improvements.
LNSC is more sensitive than UFC or DST for detection of CD recurrence. Prompt intervention when LNSC is elevated, despite normal UFC, may yield significant clinical benefit for many patients with CD. Early treatment for patients with recurrent CD should be prospectively evaluated, utilizing LNSC elevation as an early biochemical marker.
ACTH = adrenocorticotropic hormone CD = Cushing disease CS = Cushing syndrome CV = coefficient of variation DST = dexamethasone suppression test IPSS = inferior petrosal sinus sampling LNSC = late-night salivary cortisol QoL = quality of life TSS = transsphenoidal adenoma resection UFC = urinary free cortisol.
评估生化标志物在复发性库欣病(CD)检测中的性能,以及对夜间唾液皮质醇(LNSC)升高且尿游离皮质醇(UFC)正常的复发性 CD 患者进行早期干预的潜在益处。
该设计为单中心回顾性图表审查。纳入了作者在 2008 年至 2013 年治疗的患者。术后 CD 缓解后出现异常 LNSC、UFC 或地塞米松抑制试验(DST)时定义为复发。
我们发现 15 例术后复发性 CD 患者在初次缓解后;除 1 例外,其余患者均接受 LNSC、DST 和 UFC 检查。尽管 15 例患者中有 12 例在复发时 UFC 正常,但 11 例 DST 异常,所有 14 例 LNSC 结果均有≥1 项升高。14 例患者中有 9 例(7 例 UFC 正常)在复发时显示垂体瘤的放射学证据。在 14 例有随访数据的患者中,12 例自接受治疗以来,病情明显改善。5 例患者接受重复垂体手术,4 例达到临床和生化缓解。8 例患者接受米非司酮或卡麦角林治疗,6 例显示临床和/或生化改善。3 例(2 例先前使用米非司酮)接受双侧肾上腺切除术,2 例显示临床显著改善。
LNSC 比 UFC 或 DST 更敏感,用于检测 CD 复发。尽管 UFC 正常,但 LNSC 升高时及时干预可能会为许多 CD 患者带来显著的临床获益。应前瞻性评估复发性 CD 患者的早期治疗,利用 LNSC 升高作为早期生化标志物。
ACTH = 促肾上腺皮质激素 CD = 库欣病 CS = 库欣综合征 CV = 变异系数 DST = 地塞米松抑制试验 IPSS = 岩下窦采样 LNSC = 夜间唾液皮质醇 QoL = 生活质量 TSS = 经蝶窦腺瘤切除术 UFC = 尿游离皮质醇。